PIM
Partner Investment Management Portfolio holdings
AUM
$13.9M
This Quarter Return
-13.53%
1 Year Return
+49.21%
3 Year Return
+140.34%
5 Year Return
+258.27%
10 Year Return
–
AUM
$75M
AUM Growth
+$75M
(-36%)
Cap. Flow
-$26.9M
Cap. Flow
% of AUM
-35.91%
Top 10 Holdings %
Top 10 Hldgs %
39.93%
Holding
132
New
20
Increased
24
Reduced
27
Closed
39
Top Buys
| 1 |
Microchip Technology
MCHP
|
$1.94M |
| 2 |
GoDaddy
GDDY
|
$1.82M |
| 3 |
Blackrock
BLK
|
$1.71M |
| 4 |
Thermo Fisher Scientific
TMO
|
$1.14M |
| 5 |
PayPal
PYPL
|
$924K |
Top Sells
| 1 |
Viatris
VTRS
|
$2.54M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$2.36M |
| 3 |
Spotify
SPOT
|
$1.91M |
| 4 |
Agilent Technologies
A
|
$1.72M |
| 5 |
Apple
AAPL
|
$1.67M |
Sector Composition
| 1 | Healthcare | 57.45% |
| 2 | Technology | 20.64% |
| 3 | Financials | 6.8% |
| 4 | Communication Services | 4.37% |
| 5 | Consumer Discretionary | 3.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
UBX
1
DELISTED
Unity Biotechnology
UBX
| $5.02M | 6.27% | 308,730 | – | – |
|
|
ALLK
2
DELISTED
Allakos
ALLK
| $4.3M | 5.38% | 88,079 -46 | -0.1% | -$2.25K |
|
|
NTGN
3
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $4.19M | 5.23% | 832,358 +3 | +0% | +$15 |
|
|
4
GoDaddy
GDDY
$20.5B
| $3.71M | 4.63% | 56,532 +27,676 | +96% | +$1.82M |
|
5
Elevance Health
ELV
$71.8B
| $2.29M | 2.86% | 8,722 -1,683 | -16% | -$442K |
|
6
Humana
HUM
$36.5B
| $2.26M | 2.83% | 7,902 +1,268 | +19% | +$363K |
|
7
Amazon
AMZN
$2.44T
| $2.1M | 2.63% | 1,400 +563 | +67% | +$846K |
|
8
Salesforce
CRM
$245B
| $2.1M | 2.62% | 15,301 +1,167 | +8% | +$160K |
|
|
9
PayPal
PYPL
$67.1B
| $2.05M | 2.56% | 24,389 +10,985 | +82% | +$924K |
|
|
10
Microchip Technology
MCHP
$35.1B
| $1.94M | 2.42% | +26,975 | New | +$1.94M |
|
11
Microsoft
MSFT
$3.77T
| $1.8M | 2.25% | 17,754 +8,837 | +99% | +$897K |
|
12
Alphabet (Google) Class A
GOOGL
$2.57T
| $1.73M | 2.16% | 1,656 -640 | -28% | -$669K |
|
|
13
Blackrock
BLK
$175B
| $1.71M | 2.14% | +4,358 | New | +$1.71M |
|
|
ALNA
14
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $1.65M | 2.05% | 301,889 | – | – |
|
15
Edwards Lifesciences
EW
$47.8B
| $1.6M | 2% | 10,450 +259 | +3% | +$39.7K |
|
16
Abbott
ABT
$231B
| $1.6M | 2% | 22,118 -1,807 | -8% | -$131K |
|
|
ARNA
17
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.54M | 1.92% | 39,408 +4,728 | +14% | +$184K |
|
18
Penumbra
PEN
$10.6B
| $1.39M | 1.73% | 11,346 +2,093 | +23% | +$256K |
|
19
Zimmer Biomet
ZBH
$21B
| $1.31M | 1.64% | 12,649 -1,667 | -12% | -$173K |
|
20
Intuit
INTU
$186B
| $1.26M | 1.57% | 6,380 -4,142 | -39% | -$815K |
|
21
Esperion Therapeutics
ESPR
$448M
| $1.17M | 1.46% | 25,341 -99 | -0.4% | -$4.56K |
|
22
UnitedHealth
UNH
$281B
| $1.16M | 1.45% | 4,654 +234 | +5% | +$58.3K |
|
|
23
Thermo Fisher Scientific
TMO
$186B
| $1.14M | 1.42% | +5,076 | New | +$1.14M |
|
24
CME Group
CME
$96B
| $1.08M | 1.35% | 5,728 +2,439 | +74% | +$459K |
|
|
ONCE
25
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.04M | 1.29% | 26,477 +16,778 | +173% | +$656K |
|